Acupuncture treatment of glaucoma based on radar plots: A protocol for an overview of systematic reviews.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
24 Sep 2021
24 Sep 2021
Historique:
received:
29
08
2021
accepted:
31
08
2021
entrez:
24
9
2021
pubmed:
25
9
2021
medline:
6
10
2021
Statut:
ppublish
Résumé
Glaucoma is the second most blinding eye disease in the world. Currently, lowering the intraocular pressure through various methods is the main treatment of glaucoma. Acupuncture has been effectively and safely used in the treatment of glaucoma. However, the evidence for the efficacy of acupuncture in the treatment of glaucoma is controversial, leading to inconsistent findings from systematic evaluations at abroad and home. Therefore, this protocol aims to provide a multivariate evaluation on the quality of evidences from current systematic reviews (SRs) and/or meta-analyzes (MAs) of acupuncture in the treatment of glaucoma, and literature quality, thus providing an intuitive and reliable evidence synthesis and basis for clinical decision making. MAs/SRs about the acupuncture treatment of glaucoma will be searched online, including Chinese Biomedical Literature Database (CBM), China Science and Technology Journal Database (VIP), China National Knowledge Infrastructure (CNKI), WanFang Database (WF), Web of Science, Embase, PubMed, and Cochrane Library. Two investigators will independently screen literatures according to inclusion and exclusion criteria and extract data. A multivariate evaluation of the included literature will be performed by depicting radar plots in 6 aspects as follows: Year of publication, study type, SRs assessment through the Assessment of Multiple Systematic Reviews 2 (AMSTAR 2), literature quality assessment through the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA), homogeneity, and publication bias. The Grading of Recommendations Assessment, Development, and Evaluation evidence quality assessment tool will be used to grade and evaluate the quality of outcome indicators of the included literatures. This study will be submitted for publication in a peer-reviewed journal. We would like to provide a visual and scientific approach for clinical decision making of acupuncture treatment of glaucoma through a accessible and useful assessment of systematic reviews.
Sections du résumé
BACKGROUND
BACKGROUND
Glaucoma is the second most blinding eye disease in the world. Currently, lowering the intraocular pressure through various methods is the main treatment of glaucoma. Acupuncture has been effectively and safely used in the treatment of glaucoma. However, the evidence for the efficacy of acupuncture in the treatment of glaucoma is controversial, leading to inconsistent findings from systematic evaluations at abroad and home. Therefore, this protocol aims to provide a multivariate evaluation on the quality of evidences from current systematic reviews (SRs) and/or meta-analyzes (MAs) of acupuncture in the treatment of glaucoma, and literature quality, thus providing an intuitive and reliable evidence synthesis and basis for clinical decision making.
METHODS
METHODS
MAs/SRs about the acupuncture treatment of glaucoma will be searched online, including Chinese Biomedical Literature Database (CBM), China Science and Technology Journal Database (VIP), China National Knowledge Infrastructure (CNKI), WanFang Database (WF), Web of Science, Embase, PubMed, and Cochrane Library. Two investigators will independently screen literatures according to inclusion and exclusion criteria and extract data. A multivariate evaluation of the included literature will be performed by depicting radar plots in 6 aspects as follows: Year of publication, study type, SRs assessment through the Assessment of Multiple Systematic Reviews 2 (AMSTAR 2), literature quality assessment through the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA), homogeneity, and publication bias. The Grading of Recommendations Assessment, Development, and Evaluation evidence quality assessment tool will be used to grade and evaluate the quality of outcome indicators of the included literatures.
RESULTS
RESULTS
This study will be submitted for publication in a peer-reviewed journal.
CONCLUSION
CONCLUSIONS
We would like to provide a visual and scientific approach for clinical decision making of acupuncture treatment of glaucoma through a accessible and useful assessment of systematic reviews.
Identifiants
pubmed: 34559130
doi: 10.1097/MD.0000000000027261
pii: 00005792-202109240-00039
pmc: PMC8462583
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e27261Subventions
Organisme : Hebei Medical Appropriate Technology Tracking Project
ID : G2018074
Informations de copyright
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no conflicts of interests to disclose.
Références
Daba KT, Gessesse GW, Sori SB. Proportion of glaucoma among voluntary people coming for glaucoma screening program at Jimma University Department of Ophthalmology, Jimma, Ethiopia. Ethiop J Health Sci 2020;30:13–22.
Acharya UR, Dua S, Du X, Sree S, V., Chua CK. Automated diagnosis of glaucoma using texture and higher order spectra features. IEEE Transactions Information Technol Biomed 2011;15:449–55.
Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, de Vincentiis M. Emerging concepts in glaucoma and review of the literature. Am J Med 2016;129:1000e1007-1000.e1013.
Francesca C, Tian K, Shannon SG, Milena P. Current perspective of neuroprotection and glaucoma. Clin Ophthalmol 2015;9:2109–18.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262–7.
Salari N, Bokaee S, Farshchian N, Mohammadi M, Kazeminia M. The role of polymorphisms rs2070744 and rs1799983 eNOS gene in patients with POAG: a systematic review and meta-analysis. Int Ophthalmol 2021;41:2747–63.
Ulhaq ZS. Vitamin D and its receptor polymorphisms are associated with glaucoma. J Fr Ophtalmol 2020;43:1009–19.
Li X. Current research on clinical treatment of glaucoma. J Clin Ophthalmol 2009;17:375–8.
Xiao X, Xiao Q. Research progress on drug treatment of glaucoma. China Med Herald 2011;08:07–8.
Chao L, Na L, Bin L, Botao Z, Shuaijie L. A meta-analysis of neuroprotective effect for traditional Chinese medicine (TCM) in the treatment of glaucoma. Open Med (Warsaw, Poland) 2016;11:25–30.
Yang Y, Ma QY, Yang Y, et al. Evidence-based practice guideline of Chinese herbal medicine for primary open-angle glaucoma (qingfeng -neizhang). Medicine (Baltimore) 2018;97:e0126.
Mi XS, Zhong JX, Chang RC, So KF. Research advances on the usage of traditional Chinese medicine for neuroprotection in glaucoma. J Integr Med 2013;11:233–40.
Guo M, Lu X. Review of traditional Chinese medicine for glaucoma. J Chin Ophthalmol Otorhinolaryngol 2019;9:51–3.
Li M, Zhao H, Wang X, Li C. Origin of the name and concept of five wind-type internal obstructions disease. Traditi Chin Med 2019;008:87–90.
Gao R, Shi C, Tian J, Kang Z. Systematic review of randomized controlled trials of acupuncture for glaucoma. Chin Acupunct Moxibustion 2011;31:1142–5.
Liu J, Xu H, Zhang J, Ying JW, Shen FJ. Professor ZHANG Ren's clinical experience of acupuncture for glaucoma. Zhongguo zhen jiu = Chinese acupuncture & moxibustion 2020;40:1338–42.
Xu H, Wang S, Guo MH. ZHANG Ren's experience of treatment on glaucoma with acupuncture. Zhongguo zhen jiu = Chinese acupuncture & moxibustion 2012;32:444–7.
Chen SY, Yieh FS, Liao WL, Li TC, Hsieh CL. Effect of acupuncture on intraocular pressure in glaucoma patients: a single-blinded, randomized, controlled trial. Evid Based Complement Alternat Med 2020;2020:7208081.
Law SK, Wang L, Li T. Acupuncture for glaucoma. Cochrane Database Syst Rev 2020;2:Cd006030.
Welte AK, Hahn U, Büssing A, Krummenauer F. Systematic review of the application of complementary and alternative medicine and their potential therapeutic benefits in the treatment of ophthalmology patients. Klinische Monatsblatter fur Augenheilkunde 2017;234:686–96.
Law SK, Li T. Acupuncture for glaucoma. Cochrane Database Syst Rev 2013;(5):Cd006030.
Law SK, Li T. Acupuncture for glaucoma. Cochrane Database Syst Rev 2007;(4):Cd006030.
Bougioukas KI, Liakos A, Tsapas A, Ntzani E, Haidich AB. Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms. J Clin Epidemiol 2018;93:09–24.
Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ (Clinical research ed) 2017;358:j4008.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264–9. w264.
Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ (Clinical research ed) 2004;328:1490.
Irwig L, Macaskill P, Berry G, Glasziou P. Bias in meta-analysis detected by a simple, graphical test. Graphical test is itself biased. BMJ (Clinical research ed) 1998;316:470author reply 470-471.
Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (Clinical research ed) 2015;350:g7647.